Molly Niffenegger

Cooley advised venture capital firm Upfront Ventures on its fundraise of more than $650 million to be deployed across three unique funds focused on various stages of the startup life cycle – the firm’s seventh early-stage fund, Upfront VII, which closed with $280 million in capital commitments; its third growth-stage fund, Upfront Growth III, with $200 million; and its Continuation Fund, with more than $175 million. Lawyers John Dado and Will Newsom led the Cooley team advising Upfront Ventures. 

Cooley advised the initial purchasers on BigCommerce Holding’s offering of $345 million aggregate principal amount of 0.25% Convertible Senior Notes due 2026. Morgan Stanley, Goldman Sachs and BofA Securities acted as joint book-running managers for the offering. BigCommerce, whose securities trade on the Nasdaq Global Market under the symbol BIGC, is a leading software-as-a-service ecommerce platform. Partners Nicole Brookshire, Mischi a Marca, Jason Savich and Darren Destefano led the Cooley team.

Cooley advised DailyPay, an on-demand pay solution for enterprises, on its $175 million Series D financing round, as well as its $325 million of credit capital from various sources. Sacha Ross and Ariel Rom led the Cooley team advising DailyPay on the investments, which propelled the fintech company to unicorn status.

Cooley advised the underwriters on Vocera Communications’ offering of $200 million principal amount of 0.50% convertible senior notes due 2026. Vocera Communications, whose securities trade on the New York Stock Exchange under the symbol VCRA, is a recognized leader in clinical communication and workflow solutions. Partners John McKenna, Mischi a Marca and Jason Savich led the Cooley team.

Cooley advised MannKind on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. MannKind, whose securities trade on the Nasdaq Global Market under the symbol MNKD, focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Partners Sean Clayton, Mischi a Marca and Jason Savich led the Cooley team.